XT4 logo

NanoEcho DB:XT4 Stock Report

Last Price

€0.016

Market Cap

€3.9m

7D

-12.8%

1Y

n/a

Updated

21 Oct, 2024

Data

Company Financials

XT4 Stock Overview

Develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes.

XT4 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

NanoEcho AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for NanoEcho
Historical stock prices
Current Share PriceSEK 0.016
52 Week HighSEK 0.026
52 Week LowSEK 0.013
Beta0
11 Month Change-34.14%
3 Month Changen/a
1 Year Changen/a
33 Year Changen/a
5 Year Changen/a
Change since IPO-33.33%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

XT4DE Medical EquipmentDE Market
7D-12.8%-0.6%1.0%
1Yn/a10.5%19.0%

Return vs Industry: Insufficient data to determine how XT4 performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how XT4 performed against the German Market.

Price Volatility

Is XT4's price volatile compared to industry and market?
XT4 volatility
XT4 Average Weekly Movement37.3%
Medical Equipment Industry Average Movement5.1%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.0%
10% least volatile stocks in DE Market2.4%

Stable Share Price: XT4's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine XT4's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2013n/aLinda Perssonnanoecho.se

NanoEcho AB (publ) develops diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden.

NanoEcho AB (publ) Fundamentals Summary

How do NanoEcho's earnings and revenue compare to its market cap?
XT4 fundamental statistics
Market cap€3.94m
Earnings (TTM)€0
Revenue (TTM)n/a

n/a

P/E Ratio

n/a

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
XT4 income statement (TTM)
Revenue€0
Cost of Revenue€0
Gross Profit€0
Other Expenses€0
Earnings€0

Last Reported Earnings

n/a

Next Earnings Date

Oct 24, 2024

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did XT4 perform over the long term?

See historical performance and comparison